Atai stock forecast.

CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93. On Friday 11/24/2023 the closing price of the ATAI Life Sciences N.V. Registered Shs share was $1.10 on NAS. Compared to the opening price on Friday 11/24/2023 on NAS of $1.12, this is a drop of 1 ...ATAI Life Sciences N.V. Common Shares (ATAI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Track ATAI Life Sciences N.V. (ATAI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Economies.com provides you with ATA Inc share price (ATAI) listed in the stock exchange, including the low, high, opening and closing price.3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.ATAI Life Sciences N.V. analyst ratings, historical stock prices, earnings estimates & actuals. ATAI updated stock price target summary.

CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93.

15. 6. 2021. ... Since Atai Life Sciences is only going public, we don't have any forecast for the stock. Also, being a clinical-stage company, we don't have ...4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the …Web2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...Complete ATAI Life Sciences N.V. stock information by Barron's. View real-time ATAI stock price and news, along with industry-best analysis.According to TipRanks, Palomeque has an average return of -14.1% and a 28.57% success rate on recommended stocks. Currently, the analyst consensus on ATAI Life Sciences is a Strong Buy with an average price target of $13.75.See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $4.96 and a one-year low of $1.14. Sep 30, 2023.

Find the latest Jet.AI Inc. (JTAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...

ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.

ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32. 4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the company's stock price to reach $12.80 in the next twelve months. This suggests a possible upside of 1,063.6% from the stock's current price.Economies.com provides you with ATA Inc share price (ATAI) listed in the stock exchange, including the low, high, opening and closing price.About Pre-Market Quotes. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. NVIDIA Corporation Common Stock. ATAI Life Sciences N ...Aug 14, 2023 · Atai Life Sciences is forecasted to grow earnings and revenue by 20.7% and 73.6% per annum respectively. EPS is expected to grow by 29.2%. Return on equity is forecast to be -69.3% in 3 years.

Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebNovember 30, 2023. EPS forecast (this quarter) -$1.25. Annual revenue (last year) $244.7M. Annual profit (last year) -$358.7M. Net profit margin.Find the latest CXApp Inc. (CXAI) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid Term ...A. While ratings are subjective and will change, the latest ATAI Life Sciences ( ATAI) rating was a reiterated with a price target of $0.00 to $20.00. The current price ATAI Life Sciences ( ATAI ...Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

View the latest ATAI Life Sciences N.V. (ATAI) stock price, news, historical charts, analyst ratings and financial information from WSJ.Find real-time CYBN - Cybin Inc stock quotes, company profile, news and forecasts from CNN Business.

ATAI – ATAI Life Sciences N.V (ATAI), Compass Pathways Plc (CMPS), and Mind Medicine Holdings (MNMD) are 3 stocks that are looking to commercialize psychedelics for medical use. Investors should keep them on their radars as they have massive long-term potential. Norms and regulations in society can change in the span of …Apr 6, 2023 · The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ... 2023 Outlook Reports. ... The small-cap market has been invaded by a flurry of psychedelics stocks to watch thanks to new company launches. ... ATAI Life Sciences is a clinical-stage biopharma ...Sep 9, 2022 · Presently, ATAI is trading below its 20W EMA, which is an extremely serious red flag. In fact, ATAI only closed above its 20W EMA once, back in late 2021. It’s just that simple to determine if the stock is or was ever a buy. Quick answer – NO! In 2020 and 2021, ATAI spent almost $60M total on R&D. Atai Life Sciences N.V. Market Cap: 184.27M, Enterprise value: 101.26M, P/E: -1.93, PEG ratio: -0.17, EPS: -0.42, Revenue: 334K, EBITDA: -129.47M, ...Find real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.atai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.

ATA Inc-China Net Income Forecast for 2023 - 2025 - 2030. In the last year, ATA Inc-China has seen a decline in its Net Income, from $-169.84M to $-167.81M – a 1.20% decrease. In the next year, analysts predict that Net Income will reach $-169.84M – an increase of 1.21%. For the next nine years, the forecast is for Net Income to grow by 0.80%.

The average Cabaletta Bio stock price prediction forecasts a potential upside of 75.22% from the current CABA share price of $18.67. What is CABA's forecast return on equity (ROE) for 2023-2026? (NASDAQ: CABA) forecast ROE is N/A, which is considered weak.

3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...43.55. -2.16%. 5.29M. Find the latest ATAI Life Sciences BV (ATAI) stock forecast, 12-month price target, predictions and analyst recommendations.WebAbout the ATAI Life Sciences N.V. stock forecast. As of 2023 November 11, Saturday current price of ATAI stock is 1.160$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. ATAI Life Sciences N.V. stock price has been showing a declining tendency so we believe that similar market segments …25. 10. 2023. ... ... Atai in early October, with a price target of $20. Its closing price on Oct. 24 was $1.23. The very same week, Atai announced it had ...ADMA Stock 12 Months Forecast. $6.00. (51.90% Upside) Based on 2 Wall Street analysts offering 12 month price targets for ADMA Biologics in the last 3 months. The average price target is $6.00 with a high forecast of $7.00 and a low forecast of $5.00. The average price target represents a 51.90% change from the last price of $3.95.According to Atai Life Sciences's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.18478. At the end of ...Nov 29, 2023 · Analyst Forecast. According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. Since Atai Life Sciences is only going public, we don’t have any forecast for the stock. Also, being a clinical-stage company, we don’t have earnings-based metrics to value the stock.Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ...Stock Price Forecast. The 6 analysts offering 12-month price forecasts for ATAI Life Sciences NV have a median target of 11.00, with a high estimate of 21.00 and a low estimate of 5.10.

-15.00(-0.11%) Russell 2000 1,807.50 +11.96(+0.67%) Crude Oil 75.54 -1.56(-2.02%) Gold 2,003.00 +10.20(+0.51%) Atai Life Sciences N.V. (ATAI) NasdaqGM - NasdaqGM Real Time Price. Currency in...ATAI Life Sciences N.V. stock price forecast for further price development down to -32.20% (time horizon: 1 day) and price target of 1.11 USD. Short-term (time horizon: 2 weeks) ATAI Life Sciences N.V. share price prediction for 2024-01-12 with daily closed price projections7 Wall Street research analysts have issued twelve-month price targets for Mind Medicine (MindMed)'s shares. Their MNMD share price targets range from $7.00 to $75.00. On average, they anticipate the company's share price to reach $25.43 in the next year. This suggests a possible upside of 684.8% from the stock's current price.See ATAI Life Sciences N.V. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 13.80 0.00 0.00%. The 5 analysts offering 1 year price forecasts for ATAI have a max estimate of — and a min estimate of —.Instagram:https://instagram. stocks dominosauction results treasuryleon cooperman stock picks todayzelensky national archives Historical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ... kikoff proprietary storelloyds tsb bank share price 170.02%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -6.55M. 51.13%. Get the latest Cybin Inc (CYBN) real-time ...Find the latest Atai Life Sciences N.V. (ATAI) stock quote, history, news and other vital information to help you with your stock trading and investing. is it a good time to invest in bonds With its shares down by 60% in the last 12 months and a recent layoff affecting 30% of its workforce, it's fair to say that Atai Life Sciences ( ATAI 1.87%) is having a rough go of things lately ...The average one-year price target for ATAI Life Sciences N.V. (NASDAQ:ATAI) has been revised to 12.57 / share. This is an increase of 5.04% from the prior estimate of 11.97 …Web